- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01064843
Clinical Evaluation of the Mandibular Mini-Implant Overdenture
May 29, 2014 updated by: 3M
Stabilization of existing full lower dentures by means of mini-dental implants (MDI).
To test whether 4 mini-implants placed at the front of the lower jaw can stabilize an immediately-modified existing lower denture.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
To test whether the percentage of case successes of these lower dentures supported by 4 MDIs is equal to or greater than 95% at 1 year.
Success is defined as a denture supported by implants that is functioning in the way it was intended.
Study Type
Observational
Enrollment (Actual)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada, H3A 2A7
- Faculty of Dentistry, McGill University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Dental implant
Description
Inclusion Criteria:
- Completely edentulous with last tooth extraction 2 years ago or longer.
- Patients requesting implant stabilization of existing lower conventional denture.
- Adequate space in anterior mandible for placement of 4 MDI implants.
- Able to maintain adequate oral hygiene and keep dentures clean.
- Healthy enough to have minor surgical procedures.
- Have adequate understanding of written and spoken English or French.
- Capable of providing written informed consent.
Exclusion Criteria:
- Not enough room in mandibular bone for implant height.
- Has acute or chronic symptoms of parafunctional disorders.
- History of radiotherapy to orofacial region.
- Are or have been taking bisphosphonate IV or other medications (to be evaluated by the researcher).
- Health conditions that may jeopardize treatment (to be evaluated by the researcher).
- Unable or unwilling to return for evaluations or study recalls.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
4 Imtec mini-dental implants (MDI)
4 Imtec MDI
|
4 Imtec MDI
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Success rate of mandibular overdentures supported by 4 MDIs placed in the interforaminal region in the long term.
Time Frame: 3 years
|
3 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Oral health-related quality of life and general satisfaction of patients.
Time Frame: 3 years
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jocelyne Feine, DDS, MSc, HDR, Professor, Principal Investigator
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2010
Primary Completion (ACTUAL)
March 1, 2014
Study Completion (ACTUAL)
March 1, 2014
Study Registration Dates
First Submitted
February 5, 2010
First Submitted That Met QC Criteria
February 8, 2010
First Posted (ESTIMATE)
February 9, 2010
Study Record Updates
Last Update Posted (ESTIMATE)
May 30, 2014
Last Update Submitted That Met QC Criteria
May 29, 2014
Last Verified
May 1, 2014
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 3M ESPE CR-09-020
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stabilization of a Full Lower Denture
-
Quinnipiac UniversitySole Supports, IncCompletedLower Extremity Pain of a Mechanical OriginUnited States
-
Luxembourg Institute of HealthDECATHLON SANot yet recruitingRunning-Related Injury (First-time), With a Duration of Minimum One Week | First One-day Time Loss Running-related Injury | First Musculoskeletal Complaint to the Lower Limb | First Substantial Running-related Injury | First Overuse Running-related InjuryLuxembourg
Clinical Trials on Imtec MDI
-
AstraZenecaRecruitingMucociliary ClearanceUnited States
-
AstraZenecaCompleted
-
Pearl Therapeutics, Inc.Completed
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Pearl Therapeutics, Inc.Completed
-
AstraZenecaActive, not recruitingChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Germany, Argentina, Bulgaria, Poland, Turkey, Mexico, United Kingdom
-
Medtronic DiabetesCompletedType 1 DiabetesFrance, United Kingdom, Germany
-
Pearl Therapeutics, Inc.Terminated
-
Herlev HospitalCompletedDepression | Depressive SymptomsDenmark
-
Boehringer IngelheimCompleted